| Chairpersons |
 |
Yang Shengli
Director of Division of Medical and Health Engineering, Chinese Academy of Engineering (CAE) |
|
 |
Hu Chingli
Member of the UNESCO International Bioethic Committee |
|
 |
Kurt Zatloukal
Professor, Medical University of Graz |
|
 |
Bartha Maria Knoppers
Chairman of the Public Population Project in Genomics and Society (P3G) |
|
| |
| Speakers |
 |
Andy Zaayange |
|
|
Bartha Maria Knoppers
Chairman of the Public Population Project in Genomics and Society (P3G) |
|
 |
Jim Vaught
Deputy Director of NCI-OBBR |
|
|
Kurt Zatloukal
Professor of BBMRI |
|
| + More |
|
| |
| Organizers |
|
|
| |
| Co-organizer |
|
|
|
|
| Invitation letter |
|
Dear Sir / Madam,
Greetings from The 3rd Annual Biobank China 2013!
As the largest biobank conference in China, the 3rd Annual Biobank China 2013 (ABC 2013) & China Biobanking Summit bring together a global network of professional to foster innovation for better biobanking.
The event will explore the latest news, share the best practice and feature the first-hand experience in the management and quality control of the biobanks, discuss the role of biobanks in translational research with top professionals, researchers and leaders from global renowned biobanks and institutes such as NCI BBRB, BBMRI, P3G, INSERM, KI, UK Biobank, etc., as well as hospitals, institutions and pharmaceutical companies in China.
Following the feedback from its launch in Shanghai last two years, ABC 2013 will focus on the quality management of biobank and translational research. This year, the event will be organized by Shanghai Clinical Research Center (SCRC), Shanghai Consulting & Academic Activities Center for Academicians of Chinese Academy of Engineering, Shanghai ShenKang hospital development Center and Shanghai Engineering Research Center of Biobank on Sep 26th - 28th, 2013, at Le Méridien She Shan Shanghai.
We look forward to welcoming you and your colleagues to Shanghai for what I believe will be an exciting program and a rewarding cultural experience. Please feel free to contact us at hao.ying@scrcnet.org or 86-21-33676448 if you are interested in attending the meeting. We really appreciate it if you can share the conference information to those who might be interested.
Yours sincerely
Shengli Yang, Chingli HuKurt Zatloukal, Bartha Maria Knoppers
2013-04-20 |
|
| |
| Key Sessions and Topics |
| Session 1: Translational medical research and biobank |
| Session 2: Cohort biobank construction and management |
| Session 3: Clinical disease biobank construction and management |
| Session 4: Quality management and control of biobank |
| + More |
|
| |
| Agenda |
| 26th Sep. |
| Registration 09:00-20:00 |
| China Biobanking Summit (VIP) |
Workshop I:
Biobank Management |
| 13:30-19:30 |
13:30-17:05 |
| Summit Venue (Ballroom D-E) |
Satellite Meeting Venue
(Ballroom A-B-C) |
| 27th Sep. |
| 3rd Annual Biobank China 2013 |
|
| Main Venue (Ballroom A-B-C) |
| 09:00-09:30 |
Opening Ceremony |
| 09:30-12:00 |
S1: Translational Medicine & Biobanking |
| 14:00-16:30 |
S2: Cohort studies for biobanks |
Workshop II:
Biobank Management |
| 14:30-17:00 |
Satellite Meeting Venue
(Ballroom D) |
| 28th Sep. |
| 9:00-11:30 |
S3: Disease studies for biobanks |
|
| 14:00-16:40 |
S4: Quality management systems for biobanking |
|
27th Sep.
| Time |
Presentation Title |
Speaker |
Main venue
(Ballroom A-B-C) |
Chairman:
Shengli Yang, Chingli Hu, Kurt Zatloukal, Bartha Maria Knoppers |
| 09:00-09:30 |
Welcome |
Shengli Yang |
| |
| S1: Translational Medicine & Biobank |
Chairman:
Shengli Yang, Kurt Zatloukal |
| 09:30-09:50 |
How Biobanks May Contribute to Innovation |
Kurt Zatloukal |
| 09:50-10:10 |
The application of Biobanking in Clinic: Biomarkers for Kidney Disease |
Zhihong Liu |
| 10:10-10:30 |
Biobankonomics: Developing a Sustainable Biospecimen Resource |
Jim Vaught |
| 10:30-10:45 |
Tea Break & Group Photo |
| 10:45-11:05 |
Rules of Biospecimen Resource Usage in China |
Yanrong Sun |
| 11:05-11:25 |
Towards Global Sharing of Genomic and Clinical Data |
Bartha Maria Knoppers |
| 11:25-11:45 |
Ethics Guideline for Shanghai Clinical Biobank |
Chingli Hu |
| 11:45-12:00 |
Discussion |
| |
| S2: Cohort studies for biobanks |
Chairman:
Chingli Hu, Bartha Maria Knoppers |
| 14:00-14:15 |
Shanghai Birth Cohort Study |
Jun Zhang |
| 14:15-14:30 |
Cohort Study of Kodorrie Biobank |
Zhengming Chen |
| 14:30-14:45 |
Exploration of Biobank Construction in Taiwan |
Chen-Yang Shen |
| 14:45-15:00 |
Cohort Study in Columbia University |
Deliang Tang |
| 15:00-15:15 |
Tea Break |
| 15:15-15:30 |
Construction of National Cardiovascular Biobank |
Lixin Jiang |
| 15:30-15:45 |
Gene & Environment: Prospective Cohort Study of Epidemics |
Xu Lin |
| 15:45-16:00 |
Population-Based Cohort Study in Taizhou |
Xiaofeng Wang |
| 16:00-16:15 |
Canada Child Birth Cohort Study |
William Fraser |
| 16:15-16:30 |
Discussion |
28th Sep.
| Time |
Presentation Title |
Speaker |
>
| S3: Disease studies for biobanks |
Chairman:
Jim Vaught, Jiayou Chu |
| 09:00-09:15 |
Role of Government and Society in Biobanking |
Kan Zhang |
| 09:15-09:30 |
The story of Beijing Biobank |
Peng Wang |
| 09:30-09:45 |
Exploration of Major Disease-Based Biobank Development in Shanghai |
Peiyong Zheng |
| 09:45-10:00 |
Implementing a State-of-the-Art Biorepository: The Genome Quebec-Chicoutimi Hospital Experience |
Steve Arsenault |
| 10:00-10:15 |
Tea Break |
| 10:15-10:30 |
Biobank & Data Base for Liver Cancer |
Weiping Zhou |
| 10:30-10:45 |
Study of Susceptibility Genes: the Use of Rheumatism Bio-Samples |
Huji Xu |
| 10:45-11:00 |
The Biobank of Neurology |
JinSong Wu |
| 11:00-11:15 |
Cancer Biobank: Facility Management and Services |
Lianhai Zhang |
| 11:15-11:30 |
Discussion |
| |
| S4: Quality management systems for biobanking |
Chairman:
Geogers Dagher, Yong Zhang |
| 14:00-14:15 |
Proficiency Testing (PT) Project of ISBER & Biobank |
Andy Zaayange |
| 14:15-14:30 |
Quality & Value in Biobanks |
Mark Divers |
| 14:30-14:45 |
Toward the Establishment of Indicators for Evaluating Hospital-Integrated Tumor Biobanks: Main Current Stakes & Limitations |
Paul Holfman |
| 14:45-15:00 |
Data Quality Control of Biobank |
Weiye Wang |
| 15:00-15:15 |
Tea Break |
| 15:15-15:30 |
Quality Perspectives in Biobanking |
Robert Jones |
| 15:30-15:45 |
Quality Control of Nucleic Acid in Biobank |
Yong Zhang |
| 15:45-16:00 |
Establishing a US Compliant Biorepository: Challenges & Successes |
Scott Clark |
| 16:00-16:15 |
Data Management in UK Biobank |
James Brennan |
| 16:15-16:30 |
Discussion |
| 16:30-16:40 |
Closing Ceremony |
|
|
|
|
| Registration Fee |
Only Annual Biobank China 2013
Nonprofit/Academic/Government $ 200/person
(On-site Registration $ 300/person)
Industry Standard $ 500/person |
|
Both Annual Biobank China 2013 and China Biobanking Summit
Nonprofit/Academic/Government $ 500/person
(On-site Registration $ 650/person)
Industry Standard $ 850/person |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
